ETON

Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. (ETON) has 5 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 16, 2026.

The most active filer is 10% Owner Opaleye Management Inc. with 4 filings. Insiders have net sold $7.5M over the trailing 6 months.

  • Industry:Drug Manufacturers - Specialty & Generic
  • CEO:Sean E. Brynjelsen
  • Employees:44
  • HQ:Deer Park, IL, US
  • IPO:2018-11-14

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$7.5M

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$1.0B

latest known value

Source
Sale$1.1MJul 16SEC ↗
Sale$3.4MJul 7SEC ↗
Sale$380KJul 7SEC ↗
Sale$1.0MJul 7SEC ↗
Sale$1.6MJun 17SEC ↗

Related companies

Eton Pharmaceuticals, Inc. is in the Healthcare sector.